VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

CUSIP: 921937819

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / INTERMED TERM
Total 13F shares
117,045,107
Share change
-15,485,122
Total reported value
$9,476,936,370
Price per share
$80.97
Number of holders
380
Value change
-$1,254,111,385
Number of buys
162
Number of sells
195

Security key

921937819

Report period

Q2 2018

Institutions

380

Top holders

10

Ownership snapshot

Top shareholders of BIV - VANGUARD BD INDEX FDS - INTERMED TERM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
380
Shares
117,045,107
Rows loaded
380
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders
396
Q2 2018 holders
380
Holder diff
-16
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 value Q2 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .